Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
85
NCT02296580
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2014
Completion: Sep 30, 2021
NCT02507102
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia
Start: Aug 31, 2015
Completion: Mar 26, 2018
NCT03276286
Nativis Voyager for Newly Diagnosed GBM
Start: Nov 10, 2017
Completion: May 31, 2022